Why the study?
Can the CVDPoRT algorithm accurately predict the 5-year risk of incident cardiovascular disease using self-reported population health survey data?
Can the CVDPoRT algorithm accurately predict the 5-year risk of incident cardiovascular disease using self-reported population health survey data?
The CVDPoRT algorithm accurately predicts 5-year cardiovascular disease risk using only self-reported survey data, facilitating population-level planning and individual risk assessment without requiring clinical measurements.
Answers are grounded in this paper and cite their sources.
Supports survey-based CVD risk prediction without clinical measures; leaves open external validation before clinical adoption.
BACKGROUND: Routinely collected data from large population health surveys linked to chronic disease outcomes create an opportunity to develop more complex risk-prediction algorithms. We developed a predictive algorithm to estimate 5-year risk of incident cardiovascular disease in the community setting. METHODS: We derived the Cardiovascular Disease Population Risk Tool (CVDPoRT) using prospectively collected data from Ontario respondents of the Canadian Community Health Surveys, representing 98% of the Ontario population (survey years 2001 to 2007; follow-up from 2001 to 2012) linked to hospital admission and vital statistics databases. Predictors included body mass index, hypertension, diabetes, and multiple behavioural, demographic and general health risk factors. The primary outcome was the first major cardiovascular event resulting in hospital admission or death. Death from a noncardiovascular cause was considered a competing risk. RESULTS: We included 104 219 respondents aged 20 to 105 years. There were 3709 cardiovascular events and 818 478 person-years follow-up in the combined derivation and validation cohorts (5-year cumulative incidence function, men: 0.026, 95% confidence interval [CI] 0.025-0.028; women: 0.018, 95% 0.017-0.019). The final CVDPoRT algorithm contained 12 variables, was discriminating (men: C statistic 0.82, 95% CI 0.81-0.83; women: 0.86, 95% CI 0.85-0.87) and was well-calibrated in the overall population (5-year observed cumulative incidence function v. predicted risk, men: 0.28%; women: 0.38%) and in nearly all predefined policy-relevant subgroups (206 of 208 groups). INTERPRETATION: ClinicalTrials.gov, no. NCT02267447.
No takes yet. Share an insight, caveat, or question.
Manuel et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: